CV-8102

N/A

Report date: 2024/12/25 20:00:50

Base Information

Drug NameCV-8102
Drug Alias NameCV-8102
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulantsToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsSkin MelanomaSquamous Cell Carcinoma of Head and NeckCarcinoma, Basosquamous +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumRussian FederationItaly +[8] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCurevac Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCurevac Ag
Active IndicationsN/A
Inactive IndicationsSkin MelanomaSquamous Cell Carcinoma of Head and NeckCarcinoma, Basosquamous +[6] 

Other Information

ATC CodeN/A
Related LinksN/A